CLINICAL_TRIALS
research
· 2025-06-18
Clinical Trial Update: Avenir Complete Post-Market Clinical Follow-Up Study [NA]
Summary
Zimmer Biomet's Avenir Complete post-market clinical follow-up study is active but not recruiting, monitoring patients with hip osteoarthritis and avascular nec…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Hip, Avascular Necrosis of Hip | NA | Status: ACTIVE_NOT_RECRUITING